應(yīng)用場景:如用于新型冠狀病毒的核酸快速檢測。
Established close industry-university-research cooperation relationship with Shanghai University and Suzhou Institute of Biomedical Engineering Technology, Chinese Academy of Sciences
虎年新春,為真生物旗下子公司安徽為臻傳喜訊。在2月9日國家級宣城經(jīng)濟技術(shù)開發(fā)區(qū)召開的“雙招雙引項目建設(shè)暨工業(yè)發(fā)展大會”上,安徽
2020年,瑞典皇家科學(xué)院將諾貝爾化學(xué)獎授予Jennifer Doudna教授Emmanuelle Charpentier博士以表彰她們在CRISPR/Cas9基因編輯方法上
為真生物與桐樹基因簽署十年戰(zhàn)略合作,共創(chuàng)伴隨診斷產(chǎn)品市場新概念2021年9月9日,值為真生物13周年之際,與上海桐樹基因達(dá)成3個伴隨診
Weizhenbio Bioengineering Technology Co., Ltd. founded in 2017, is a national-level high-tech enterprise focusing on the construction of immune and molecular POCT production lines. High-end medical device engineering technology research center.
Business area
Registered capital
Company patent
R & D personnel